Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Patient with advanced liver cancer (cancer that has spread to other parts of the body)
continues to receive the study drug (G-202) even though patient no longer meets the criteria
to be a part of the main treatment study. Patient's cancer responded well to receiving G-202
in the main study and will receive G-202 at the same dose given in the main study.